# VIOS – FDA Inspection, Sep 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/vios/a9f692dd-20e4-4d50-a84b-ef80da1cfa70
Source feed: FDA_Inspections

> FDA inspection 1218025 of VIOS, September 14, 2023. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218025
- Company Name: VIOS
- Inspection Date: 2023-09-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1326256 - 2026-07-09
- FDA Inspection 1043268 - 2018-02-15
- [FDA Inspection 1003678 - 2017-02-03](https://www.keypedia.com/records/fda_inspections/vios/0744ad51-6850-4ac4-9de9-a06889add2ae)
- FDA Inspection 886244 - 2014-07-02
- FDA Inspection 732394 - 2011-06-28

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/john-a-iwen/b71cb474-8485-416e-a534-ffaed0319625)

Company: https://www.keypedia.com/companies/vios/3f38b5bd-e864-41f3-bab4-4bc49186283f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
